Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,043,764 | 45,714 | 175,065 | 126,198 | 75,881 |
| Depreciation Amortization | 556 | 286 | 1,418 | 1,078 | 715 |
| Income taxes - deferred | 27,060 | 17,052 | 65,739 | 45,610 | 29,594 |
| Accounts receivable | 11,057 | 14,298 | 7,993 | 7,056 | 21,394 |
| Other Working Capital | 24,570 | 9,605 | 2,820 | 685 | 5,605 |
| Other Operating Activity | 1,095,655 | -6,784 | 20,728 | 13,954 | -7,700 |
| Operating Cash Flow | $115,134 | $80,171 | $273,763 | $194,581 | $125,489 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13 | -13 | -136 | -163 | -97 |
| Net Acquisitions | -999,492 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-999,505 | $-13 | $-136 | $-163 | $-97 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 400,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | -120,699 | -120,699 | -120,699 |
| Common Stock Issued | 5,347 | 3,981 | 9,540 | 6,734 | 5,937 |
| Common Stock Repurchased | N/A | N/A | -126,394 | -126,394 | -126,394 |
| Other Financing Activity | -2,295 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $403,052 | $3,981 | $-237,553 | $-240,359 | $-241,156 |
| Beginning Cash Position | 657,938 | 657,938 | 621,864 | 621,864 | 621,864 |
| End Cash Position | 176,619 | 742,077 | 657,938 | 575,923 | 506,100 |
| Net Cash Flow | $-481,319 | $84,139 | $36,074 | $-45,941 | $-115,764 |
| Free Cash Flow | |||||
| Operating Cash Flow | 115,134 | 80,171 | 273,763 | 194,581 | 125,489 |
| Capital Expenditure | -13 | -13 | -136 | -163 | -97 |
| Free Cash Flow | 115,121 | 80,158 | 273,627 | 194,418 | 125,392 |